SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015281
Filing Date
2021-11-09
Accepted
2021-11-09 16:08:13
Documents
14
Period of Report
2021-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alt-20211109x8k.htm   iXBRL 8-K 45164
2 EX-99.1 alt-20211109xex99d1.htm EX-99.1 184348
3 GRAPHIC alt-20211109xex99d1002.jpg GRAPHIC 8709
  Complete submission text file 0001558370-21-015281.txt   376913

Data Files

Seq Description Document Type Size
4 EX-101.SCH alt-20211109.xsd EX-101.SCH 3049
5 EX-101.LAB alt-20211109_lab.xml EX-101.LAB 15906
6 EX-101.PRE alt-20211109_pre.xml EX-101.PRE 10119
7 EXTRACTED XBRL INSTANCE DOCUMENT alt-20211109x8k_htm.xml XML 4868
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 211392156
SIC: 2834 Pharmaceutical Preparations